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Introduction
The esophagus carcinoma has an incidence rate of 3–4
new cases per 100,000 inhabitants, per year, with a male/
female ratio of 3:1 and with a low incidence between the
VI–VII decade of life. In Italy, the incidence rate equals
2,000 new cases/year with a mortality rate of 3–5/100,000
inhabitants.
Patients and methods
During the 1997–2007 decade, 57 cases of esophageal
neoplasm were observed, of which 15 patients whose age
range was 70–85 years, 11 males and 4 females, all pre-
sented with associated cardiovascular, respiratory and
metabolic pathologies that would not allow the possibil-
ity of surgical approach. Patients enrolled in the current
study contain in their clinical history several risk factors,
and more precisely: Barrett's esophagus 2, Achalasia 3,
Reflux esophagitis 5. Two out of 15 patients were alcohol-
dependent, whereas 11/15 were heavy smokers. All
patients presented serious nutritional deficits. Diagnosis
was made after symptoms of dysphagia manifested, after
having undergone an endoscopic examination and
biopsy. Clinical staging provided for the ultrasound exam-
ination and thoracic-abdominal CT. The neoplasias were
located 12 in the cardiac region, 1 in the medio-thoracic
region, 2 in the cervical tract. There were 5 carcinomas in
situ, 4 infiltrating adenocarcinomas, 6 squamous cell car-
cinomas of which 3 stenosed, 2 ulcerated, 1 vegetative.
Hepatic metastasis was present in 8 out of the 15 cases,
lymphonodal and mediastinic in 2 cases. An endoscopic
mucosectomy was performed in the 5 patients affected by
carcinomas in situ. In the 3 patients affected with stenosed
squamous cell carcinomas, a series of dilations and pros-
thetic nitinol stent positioning (Boston Scientifics) were
undertaken in order to restore the passage as much as pos-
sible. The four infiltrating and metastatic adenocarcino-
mas were treated with chemotherapy cycles. A case of a
vegetative tumor with hepatic metastasis was treated with
Bicap use (monopolar electrode), with thermal destruc-
tion of the neoplastic tissue, and followed by a series of
treatment cycles undertaken to eradicate it. The remaining
two ulcerated cases were treated with Argon plasma coag-
ulator.
Results
In five years, four out of five patients afflicted by carci-
noma in situ treated with endoscopic mucosectomy were
free from the ailment and did not present morbidity asso-
ciated with the treatment undertaken, only one of them
passed away due to a cardiovascular cause. Patients who
underwent pneumatic dilatation and prosthetic place-
ment obtained an excellent control of the dysphagic
symptoms, especially in the first months after the pros-
thetic placement, with a considerable improvement in
quality of life, but their survival rate did not surpass 18
months. The patients guided through chemotherapy
cycles, while considering their general condition, of
comorbidity and age, have had a considerable decrease in
QL without obtaining noticeable improvements in the
survival rate. Patients treated with Argon plasma coagula-
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tor (APC) and with Bicap have had a fast progression of
the illness, a decrease in QL, and passed away in six
months due to serious hemorrhagic complications.
Conclusion
In the treatment of esophageal cancer, when diagnosed
after 70 years of age, it becomes indispensable to keep in
mind, beyond the size of the tumor and diffusion of the
ailment, the anagraphic age of the patient, the comorbid-
ity presence, which renders a "radical" therapy dispropor-
tionate. It should be outlined the principle that a good
palliation is more useful for patients of treatments which
carry heavy risk, tending to radical surgeries of dubious
use. The esophageal prosthetic placement seems to be the
treatment of choice in inoperable stenosed carcinomas
with the aim of restoring the passage and/or improving
the dysphagia.
The endoscopic mucosectomy in agreement with litera-
ture data instead obtained indications in the inoperable
carcinomas in situ. This low invasion and reliable
method, from an oncologic point of view, allows for the
complete remove of the mucous section of the lesion up
to the lamina, and thanks to the use of image magnifica-
tion techniques and the use of the Narrow Band Imaging,
it is now more precise and safe. The mucosectomy con-
tains risks comparable to a polypectomy and in regards to
other methods boasts the advantage of quick execution
and of offering a radical surgery that would not be other-
wise achievable. Treatments with Argon plasma and with
Bicap are considered to be entirely palliative, compulsory
options in extremely advanced clinical cases and for
severely malnourished patients. The chemo and radio-
therapy are often impractical and when it's possible to fol-
low the treatment, the limits placed on age and
comorbidity present, drastically reduce their efficacy. Nev-
ertheless, it continues to be imperative to improve the
quality of life in inoperable geriatric patients.Page 2 of 2
(page number not for citation purposes)
